Not Tagged
gilead sciences
['mds', 'gilead']
advances in high-risk #mds have been limited in the last 15 years, leaving considerable unmet needs for patients and physicians. mathias schulz shares why research being presented at #asco22 is so important. #meanstome 
We’re committed to creating a healthier world by delivering transformational medicines to people living with cancer. Twitter guidelines: https://t.co/m6iqKGncPZ